PRAVASISAMWAD.COM
US Ambassador to India Sergio Gor said the investments reflect the strong appeal of the American market and support the goal of increasing US-India bilateral trade to $500 billion by 2030
Indian companies have announced investments worth a record $20.5 billion in the United States during the 2026 SelectUSA Investment Summit, underlining growing business ties between the two countries.
According to the US Embassy and Consulates in India, the pharmaceutical sector made up the largest share of the commitments, accounting for more than $19.1 billion. The biggest deal came from Sun Pharmaceutical Industries, which plans to acquire New Jersey-based Organon & Co. for $11.75 billion.
-
Several other Indian drug makers, including Cipla, Dr. Reddy’s Laboratories, Lupin and Zydus Lifesciences, also announced plans to expand manufacturing, research and development, and new facilities in the US
-
These projects aim to improve medicine supplies and strengthen healthcare supply chains
In the industrial sector, JSW Steel confirmed $255 million in upgrades at its plants in Ohio and Texas. Meanwhile, 12 Indian companies together announced more than $1.1 billion in fresh projects across the country.
Ahmedabad-based Abhyuday Group committed over $900 million across five US locations, with plans to create around 1,500 jobs. Other investments include projects by Jindal Pipe, Jindal Tubular USA and Jivo Wellness.
Technology and digital infrastructure also attracted major investments. Sterlite Technologies announced a $100 million investment to support AI and telecom infrastructure, expected to create 500 jobs.
